Expanding Biologics Adoption Fuels North America Remicade Drug Market Growth
The North American Remicade drug market continues to represent a significant share of global revenue, driven by the high prevalence of autoimmune disorders such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and ankylosing spondylitis. The United States remains the largest contributor to regional demand due to advanced healthcare infrastructure, strong reimbursement frameworks, and widespread adoption of biologic therapies. Increasing awareness of chronic inflammatory diseases and ongoing investments in specialty pharmaceuticals are supporting market expansion across North America.
Read More - https://www.theinsightpartners.....com/reports/remicad
